Search Results
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia
Rituximab maintenance key to outcome improvement in mantle cell lymphoma
Rituximab vs. standard chemotherapy: which treatment benefits B-cell ALL patients more?
Promising Results for Bendamustine/Rituximab Plus Polatuzumab Vedotin in Lymphomas
Progress in treatment options for precursor B-cell ALL
Dr. Schuster on Long-Term Outcomes of Lenalidomide and Rituximab in MCL
Ibrutinib combination regimen shows substantial benefits in relapsed CLL
Redefining Patient Care in Acute Lymphoblastic Leukemia
EHA 2013: Adding obinutuzumab or rituximab to chlorambucil improves chronic lymphocytic leukaemia
Small molecule-chemotherapy combinations: ibrutinib plus rituximab for CLL
Randomised phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolen...
Future perspectives in the treatment of acute lymphoblastic leukemia
